Caterina Breitenstein Selected Research

Language Therapy (Language Training)

12/2022	Precision rehabilitation for aphasia by patient age, sex, aphasia severity, and time since stroke? A prespecified, systematic review-based, individual participant data, network, subgroup meta-analysis.
1/2019	Transcranial Direct Current Stimulation to Enhance Training Effectiveness in Chronic Post-Stroke Aphasia: A Randomized Controlled Trial Protocol.
1/2017	Intensive speech and language therapy after stroke - Authors' reply.
1/2017	Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting.
1/2015	L-dopa does not add to the success of high-intensity language training in aphasia.
9/2013	FCET2EC (From controlled experimental trial to = 2 everyday communication): How effective is intensive integrative therapy for stroke-induced chronic aphasia under routine clinical conditions? A study protocol for a randomized controlled trial.
7/2011	Short-term anomia training and electrical brain stimulation.
10/2010	Integrity of the hippocampus and surrounding white matter is correlated with language training success in aphasia.
9/2009	Imaging short- and long-term training success in chronic aphasia.
2/2008	Functional re-recruitment of dysfunctional brain areas predicts language recovery in chronic aphasia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caterina Breitenstein Research Topics

Disease

14	Aphasia (Dysphasia) 12/2022 - 01/2004
14	Stroke (Strokes) 10/2022 - 09/2004
1	Common Cold 01/2017
1	Anomia (Dysnomia) 07/2011
1	Memory Disorders (Memory Loss) 02/2009
1	Alzheimer Disease (Alzheimer's Disease) 02/2009
1	Weight Gain 12/2008
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2008
1	Hyperphagia (Overeating) 12/2008
1	Obesity 12/2008

Drug/Important Bio-Agent (IBA)

5	Dopamine (Intropin)FDA LinkGeneric 02/2009 - 10/2006
4	Levodopa (L Dopa)FDA LinkGeneric 01/2015 - 11/2006
2	Dextroamphetamine (Dexedrine)FDA LinkGeneric 10/2006 - 09/2004
1	Carbidopa (Lodosyn)FDA LinkGeneric 01/2015
1	salicylhydroxamic acid (SHAM)IBA 07/2011
1	Pharmaceutical PreparationsIBA 12/2008

Therapy/Procedure

11	Language Therapy (Language Training) 12/2022 - 01/2007
7	Therapeutics 10/2022 - 01/2004
3	Transcranial Direct Current Stimulation 01/2019 - 08/2008
2	Aftercare (After-Treatment) 01/2019 - 10/2010
1	Neurological Rehabilitation 09/2008